Medincell annual r&d spending
2021
2022
2023
2024
2025
2026
Medincell R&D Spending Growth & History (MEDCL)
Medincell's r&d spending was €26.5M for fiscal 2026.
View full Medincell company overviewMedincell annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-03-31 | €26.5M | €2.2M | +9.15% |
| 2025 | 2025-03-31 | €24.3M | €3.2M | +15.36% |
| 2024 | 2024-03-31 | €21.1M | −€6.8M | −24.53% |
| 2023 | 2023-03-31 | €27.9M | €4.3M | +18.29% |
| 2022 | 2022-03-31 | €23.6M | €4.1M | +20.78% |
| 2021 | 2021-03-31 | €19.5M | — | — |
Medincell r&d spending trends
Over the last five fiscal years, Medincell's r&d spending increased from €19.5M to €26.5M, a change of €7.0M.
About the metric
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
Calculation and source
reported R&D expense
TickerStat standardizes research and development expense reported in company official filings, including the software-specific standardized R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medincell source filings ↗